<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Tsp2022 - Latest News</title>
<link href="https://news.newswirebiz.com/rss/tsp2022/latest.xml"></link>
<updated>2026-07-21T10:30:04+00:00</updated>
<id>urn:uuid:f0ae6323-101b-a9ea-8561-9686a89752a8</id>
<entry>
<title>ASCELIA PHARMA PRESENTS RESULTS OF ORVIGLANCE FOOD EFFECT STUDY AT RSNA 2022</title>
<link href="https://news.newswirebiz.com/@tsp2022/ascelia-pharma-presents-results-of-orviglance-food-effect-study-at-rsna-2022-cd7xosznqwjv"></link>
<id>urn:uuid:9bf166cc-1d82-77f0-9399-18f981553501</id>
<summary type="html"><![CDATA[23 November 2022: Ascelia Pharma AB (publ) – a biopharmaceutical company focused on improving the life of people living with rare cancer conditions –  is presenting results from its Orviglance* Food Effect study at the RSNA conference 2022.]]></summary>
<updated>2022-11-25T15:24:44+00:00</updated>
</entry>
</feed>